- McCabe BF. Autoimmune sensorineural hearing loss. Ann Otol Rhinol Laryngol 1979; 88: 585-9.
- Ryan AF, Keithley EM, Harris JP. Autoimmune inner ear disorders. Curr Opin Neurol 2001; 14: 35-40.
- Boulassel MR, Tomasi JP, Deggouj N, Gersdorff M. Coch5b2 is a target antigen of anti-inner ear antibodies in autoimmune inner ear diseases. Otol Neurotol 2001; 22: 614-8.
- Cao MY, Dupriez VJ, Rider MH, et al. Myelin protein Po as a potential autoantigen in autoimmune inner ear disease. FASEB J 1996; 10: 1635-40.
- Soliman AM, Zanetti F. Improvements of a method for testing autoantibodies in sensorineural hearing loss. Adv Otorhinolaryngol 1988; 39: 13-7.
- Soliman AM. Optimizing immunofluorescence for the testing of autoantibodies in inner ear disorders. Arch Otorhinolaryngol 1988; 245: 28-35.
- Welling DB. Clinical evaluation and treatment of immune-mediated inner ear disease. Ear Nose Throat J 1996; 75: 301-5.
- Froehlich F, Fried M, Gonvers JJ, Saraga E, Thorens J, Pecoud A. Association of Crohn's disease and Cogan's syndrome. Dig Dis Sei 1994; 39: 1134-7.
- Levitan HL. The etiologic significance of deafness in ulcerative colitis. Int J Psychiatry Med 1973; 4: 373-87.
- Bachmeyer C, Leclerc-Landgraf N, Laurette F, et al. Acute autoimmune sensorineural hearing loss associated with Crohn's disease. Am J Gastroenterd 1998; 93: 2565-7.
- Stone JH, Francis HW. Immune-mediated inner ear disease. Curr Opin Rheumatol 2000; 12: 32-40.
- Roland JT. Autoimmune inner ear disease. Curr Rheumatol Rep 2000; 2: 171-4.
- Bernstein JM. The immunology of autoimmune disease of the inner ear. In: Bernstein JM, Ogra PL, eds. Immunology of the ear. New York. Raven Press, 1987: 419-26.
- Wakefield AJ, Sawyerr AM, Dhillon AP, et al. Pathogenesis of Crohn's disease: multifocal gastrointestinal infarctioa Lancet 1989; 2: 1057-62.
- Parnes LS, Sun AH, Freeman DJ. Corticosteroid pharmacokinetics in the inner ear fluids: an animal study followed by clinical application. Laryngoscope 1999; 109: 1-17.
- Matteson EL, Tirzaman O, Facer GW, et al. Use of methotrexate for autoimmune hearing loss. Ann Otol Rhinol Laryngol 2000; 109: 710-4.
- Mcdermot MF. TNF and TNFR biology in health and disease. Cell MoI Biol (Noisy-le-grand) 2001; 47: 61935.
- Braun J, De Keyser F, Brandt J, Mielants H, Sieper J, Veys E. New treatment options in spondyloarthropathies: increasing evidence for significant efficacy of anti-tumor necrosis factor therapy. Curr Opin Rheumatol 2001; 13: 245-9.
- Kalden JR, Scott DL, Smolen JS, et al. Improved functional ability in patients with rheumatoid arthritis-longterm treatment with leflunomide versus sulfasalazine. European Leflunomide Study Group. J Rheumatol 2001; 28: 1983-91.
- Koh ET. New disease modifying agents in adult rheumatoid arthritis. Ann Acad Med Singapore 2001 ; 30:170-3.
- Meyer O. Role of anti-TNF therapy in rheumatoid arthritis. Presse Med 2000; 29: 463-8in French.
Autoimmune Sensorineural Hearing Loss Improved By Tumor Necrosis Factor-α Blockade: A Case Report
Reprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.